The pill version of Wegovy, approved two weeks ago, went on sale today at more than 70,000 US pharmacies, including CVS and Costco, and through telehealth companies. The price is the news. Self-pay patients start at $149 a month for the lowest dose — about five dollars a day, the company notes — with the middle dose at $149 until mid-April and $199 after, and the highest doses at $299. People with commercial insurance can pay as little as $25 with a savings offer. That is the first time a drug with randomized, placebo-controlled trial evidence behind it has been priced in the same range as the wearable subscriptions, biomarker memberships and supplement stacks that make up the longevity aisle. The comparison is worth making carefully.
What $149 to $299 a month buys here. In the trial that supported approval, 307 adults took the pill or a placebo for 64 weeks: 13.6% of body weight lost versus 2.4%, counting everyone who was randomized, and 16.6% versus 2.7% among those who stayed on it; three in four pill users lost at least 5% of their weight against fewer than one in three on placebo. Nausea, diarrhea and vomiting were the common side effects. It is indicated for adults with obesity, or overweight plus a weight-related condition, alongside diet and activity. And it is a chronic treatment: the evidence from the injectable version is that most weight returns within a year of stopping. So the honest price is not $149. It is $149 to $299 a month for as long as the benefit is wanted.
Loree’s takeFor the right patient this is a real option, and the price drop will bring it to people who could not get it before. My concern is the person it is not for: a healthy-weight patient who has read that GLP-1s are longevity drugs and now finds one at Costco for the cost of a ring subscription. There is no evidence for that use, the side effects are real, and the body wants its weight back when the pill stops. Same molecule, two different decisions.
Ben’s takePut the two subscriptions side by side. One is $199 a year for a band that reports your sleep and has never been required to show it changes an outcome. The other is $149 to $299 a month for a drug that lost 13.6% of body weight against placebo in a randomized trial and has a cardiovascular-outcomes study behind the injectable. The longevity industry has spent a decade pricing itself like medicine. Today medicine priced itself like the longevity industry, and the difference in evidence per dollar is now visible on a shelf.
Why it matters to a recovering optimizer. The pill does not change the fundamentals; it changes the arithmetic around them. If you are deciding how to spend a monthly health budget, this is a useful benchmark: a validated drug for a diagnosed condition now costs about what the unvalidated products do. Anything in the longevity aisle at that price should be able to show you a trial like this one. Almost nothing can.
Before paying a monthly price for any health product, ask for the trial. A drug at Costco now sets the bar.
This post reports on evidence and expert disagreement. It is not medical advice; decisions about treatment belong with you and your clinician.